Skip to main content
OpenTrials
Completed

NCT Number: NCT03859713

Optimize Low Back Pain

The objective of this study is to improve health care for patients with chronic LBP and increase the likelihood that patients obtain outcomes that matter most to them. The investigators will accomplish our goal using a sequential multiple randomization (SMART) design comparing the effectiveness of Phase 1 (PT v. CBT) treatments for patients with chronic LBP; and among patient non-responsive to Phase I treatment, compare the effectiveness of Phase II treatments (switching to PT or CBT v. mindfulness). Effectiveness will be based on patient-centered outcomes. Sub-aims will compare main effects of Phase 1 and 2 treatment options and the sequencing effects of different treatment combinations.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–64 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Johns Hopkins University, Baltimore, Maryland, United States

Loading trial locations.

About this study

The study uses a sequential multiple randomization (SMART) design. The study will compare the effectiveness of common first-line treatments for chronic LBP: PT or CBT. Initial treatment will be 8 weeks duration with re-evaluation at 10-weeks after enrollment to allow time to complete treatment. At the 10-week assessment researchers will examine if the patient has responded to initial treatment using a patient-centered, validated definition of successful response based on 50% improvement in the Oswestry Disability Index (ODI). Patients who are responders to initial treatment will receive up to 2 additional sessions of the same treatment to assist transition to self-management. Non-responders will be re-randomized to a second treatment strategy of either switching to the other initial treatment (i.e., patients receiving PT switch to CBT or vice versa), or mindfulness. The second treatment phase is also 8 weeks in duration. Additional follow-ups occur 26- and 52 weeks after enrollment.

The study has two co-primary outcomes; function and pain. The investigators will use the ODI, a well-validated, reliable and responsive patient-reported measure of LBP-related function recommended by the NIH Back Pain Task Force. The investigators will assess pain intensity with 0-10 ratings ('0' indicating no pain and '10' worst imaginable pain). Separate ratings are made for current, worst and best pain over the past 24 hours with an average computed to represent pain intensity. Secondary outcomes will assess dimensions of quality of life, work and healthcare utilization.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 - 64 years at the time of enrollment.
  • Meets NIH Task Force definition of chronic LBP based on two questions: 1) How long has LBP has been an ongoing problem for you? and 2) How often has LBP been an ongoing problem for you over the past 6 months? A response of greater than 3 months to question 1, and "at least half the days in the past 6 months" to question 2 is required to satisfy the NIH definition of chronic LBP.
  • Healthcare visit for LBP in the past 90 days.
  • At least moderate levels of pain and disability requiring ODI score >24 and pain intensity rating > 4.
  • Has access to two-way video technology, such as smartphone, iPad/tablet, or laptop with webcam for telehealth visits.

Exclusion criteria

  • Evidence of serious pathology as a cause of LBP including neoplasm, inflammatory disease (e.g., ankylosing spondylitis), vertebral osteomyelitis, etc.
  • Evidence of a specific spinal pathology as the cause of LBP including spine fracture, spinal stenosis, radiculopathy, etc.
  • Knowingly pregnant
  • Has received physical therapy for LBP; or CBT or mindfulness for any reason with a provider in prior 90 days
  • Currently receiving substance use disorder treatment
  • Any lumbar spine surgery in the past year.

Treatment and study plan

Physical Therapy

Behavioral

Evidence-based physical therapy provided in 8 individual sessions including patient education, exercise instruction and manual therapy.

Cognitive behavioral therapy

Behavioral

Evidence-based cognitive behavioral therapy provided in 8 individual sessions focused on key components of CBT; 1) identifying and monitoring maladaptive cognitions, 2) developing coping strategies (e.g., distraction, relaxation, etc.), 3) setting and working towards behavioral goals, especially focused on physical activity, and 4) focusing on self-management skills and home instruction

Mindfulness

Behavioral

Mindfulness is provided in 8 individual sessions. Focus of sessions is cognitive reappraisal, positive savoring and mindfulness practices.

Other names: Mindfulness-Oriented Recovery Enhancement

Phase I Treatment

Behavioral

Includes all participants receiving any Phase I intervention

Phase II Switching

Behavioral

Includes all participants receiving Switching as Phase II intervention

Primary outcomes

  1. Change in Oswestry Disability Index From Baseline to 10 Weeks

    Time frame: baseline, 10 weeks

    Back pain specific measure of functional disability to address Aim 1, score range 0-100 with neagtive values representing improvement in disability

  2. Change in Oswestry Disability Index From 10-weeks to 52 Weeks

    Time frame: 10 weeks, 52 weeks

    Back pain specific measure of functional disability to address Aim 2, score range 0-100 with negative values representing improvement in disability

  3. Change in Numeric Pain Intensity Rating From Baseline to 10 Weeks

    Time frame: baseline, 10 weeks

    0-10 numeric rating of pain intensity measured as average of current, best and worst pain ratings in past 24 hours to address Aim 1. Negative values represent a reduction in pain intensity.

  4. Change in Numeric Pain Intensity Rating From 10-weeks to 52 Weeks

    Time frame: 10 weeks, 52 weeks

    0-10 numeric rating of pain intensity measured as average of current, best and worst pain ratings in past 24 hours to address Aim 2. Negative values represent an improvement in pain intensity.

Secondary outcomes

  1. Health-related Quality of Life

    Time frame: baseline, 10 weeks, 26 weeks, 52 weeks

    PROMIS-29 subscales scores reported across 7 domains

  2. Change in Pain Interference From Baseline to 10 Weeks

    Time frame: baseline, 10 weeks

    Patient-Reported Outcomes Information System (PROMIS) 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10. negative scores indicate improvement in pain interference.

  3. Change in Fatigue From Baseline to !0 Weeks

    Time frame: baseline, 10 weeks

    Patient-Reported Outcomes Information System (PROMIS) 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10. Negative values indicate greater improvement in fatigue.

  4. Change in Sleep Disturbance From Baseline to 10 Weeks

    Time frame: baseline, 10 weeks

    Patient-Reported Outcomes Information System (PROMIS) 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10. Negative values indicate improvement in sleep disturbance

  5. Change in Anxiety From Baseline to 10 Weeks

    Time frame: baseline, 10 weeks

    Patient-Reported Outcomes Information System (PROMIS) 4-item short form (part of PROMIS-29)assessed as a T-score with mean = 50 and SD = 10. Negative values indicate improvement in anxiety

  6. Change in Depression From Baseline to 10 Weeks

    Time frame: baseline, 10 weeks

    Patient-Reported Outcomes Information System (PROMIS) 4-item short form assessed as a T-score with mean = 50 and SD = 10. Negative values indicate improvement in depression

  7. Change in Social Role Participation From Baseline to 10 Weeks

    Time frame: baseline, 10 weeks

    Patient-Reported Outcomes Information System (PROMIS) 4-item short form assessed as a T-score with mean = 50 and SD = 10. Negative values indicate improvement in the ability to perform social roles

  8. Health Care Utilization of Advanced Imaging for Back Pain Over 10 Weeks

    Time frame: baseline, 10 weeks

    Use of either MRI or CT for low back pain

  9. Opioid Utilization at 10-week Assessment

    Time frame: baseline, 10 weeks

    Long-term use of opioids for pain management defined as use on all or most days in the past 90 days

  10. Treatment Side Effects

    Time frame: 10 weeks

    Self-reported physical or psychological side effects of study treatments

  11. Treatment Responder

    Time frame: baseline, 10 weeks

    Dichotomous outcome based on achieving at least 50% improvement on ODI from baseline score

  12. Health Care Utilization of Injections for Back Pain Over 10 Weeks

    Time frame: baseline, 10 weeks

    Use of injections for low back pain

  13. Health Care Utilization of Radiographs for Back Pain Over 10 Weeks

    Time frame: baseline, 10 weeks

    Use of radiographs for low back pain

Sponsors and collaborators

Lead sponsor

University of Utah

Other

Collaborators

  • Patient-Centered Outcomes Research Institute

Registry information

Official study title

Optimized Multidisciplinary Treatment Programs for Nonspecific Chronic Low Back Pain

Acronym: OPTIMIZE

Important dates

Study start
2019
Primary completion
2024
Study completion
2024
First posted
Mar 1, 2019
Registry last updated
Mar 6, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.